RECURSION PHARMACEUTICALS IN shareholders Q2 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.

RECURSION PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 174,435$1,3030.01%
Rafferty Asset Management, LLC 320,413$2,393,4850.01%
E Fund Management Co., Ltd. 17,229$1290.01%
Resolute Advisors LLC 11,002$82,1850.01%
ALPS ADVISORS INC 141,396$1,056,2280.01%
CENTAURUS FINANCIAL, INC. 13,242$990.01%
PITCAIRN CO 11,763$87,8700.01%
Hudson Bay Capital Management LP 110,000$821,7000.01%
Foundations Investment Advisors, LLC 23,003$171,8320.01%
Mitsubishi UFJ Trust & Banking Corp 358,530$2,678,2190.01%
China Universal Asset Management Co., Ltd. 2,420$180.01%
Tower Research Capital LLC (TRC) 18,518$138,3300.01%
Sumitomo Mitsui Trust Holdings, Inc. 837,400$6,255,3780.01%
Vident Investment Advisory, LLC 17,849$133,3310.01%
BDO Wealth Advisors, LLC 6,082$45,4330.01%
MARTINGALE ASSET MANAGEMENT L P 25,202$188,2590.00%
MetLife Investment Management, LLC 72,161$539,0430.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 13,420$100,2480.00%
Renaissance Technologies 350,000$2,6150.00%
LAZARD ASSET MANAGEMENT LLC 345,123$2,5780.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q2 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.